VRTX vs MRNA: Which Stock is Better?
Side-by-side comparison of Vertex Pharmaceuticals Inc and Moderna Inc in 2026
VRTX
Vertex Pharmaceuticals Inc
$447.97
MRNA
Moderna Inc
$47.57
Key Metrics Comparison
| Metric | VRTX | MRNA | Winner |
|---|---|---|---|
| Market Cap | $110.97B | $18.89B | VRTX |
| P/E Ratio | 25.98 | N/A | VRTX |
| EPS (TTM) | $16.83 | $N/A | VRTX |
| Revenue Growth | 0.1% | 2.6% | MRNA |
| Gross Margin | 54.4% | -69.9% | VRTX |
Analyze VRTX
Full quant analysis
Analyze MRNA
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is VRTX or MRNA a better investment?
Comparing VRTX and MRNA: Vertex Pharmaceuticals Inc has a market cap of $110.97B while Moderna Inc has $18.89B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between VRTX and MRNA?
VRTX (Vertex Pharmaceuticals Inc) and MRNA (Moderna Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: VRTX or MRNA?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: VRTX or MRNA?
MRNA has higher revenue growth at 2.6% vs 0.1% for VRTX.
Which company is more profitable: VRTX or MRNA?
Vertex Pharmaceuticals Inc (VRTX) has higher gross margins at 54.4% compared to -69.9% for MRNA.
Which is the larger company: VRTX or MRNA?
Vertex Pharmaceuticals Inc (VRTX) is larger with a market cap of $110.97B compared to $18.89B for MRNA.
Should I buy VRTX or MRNA in 2026?
Both VRTX and MRNA have investment merit. VRTX trades at $447.97 while MRNA trades at $47.57. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between VRTX and MRNA stock?
Key differences: Market Cap ($110.97B vs $18.89B), P/E Ratio (26.0x vs N/A), Revenue Growth (0.1% vs 2.6%), Gross Margin (54.4% vs -69.9%).